Conclusive link between genetics, clinical response to warfarin uncovered

Patients with a genetic sensitivity to warfarin have higher rates of bleeding during the first several months of treatment and benefited from treatment with a different anticoagulant drug, a study has shown. The analyses suggest that using genetics to identify patients who are most at risk of bleeding, and tailoring treatment accordingly, could offer important safety benefits, particularly in the first 90 days of treatment.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1AjV4ov